Familial Chylomicronemia Syndrome Stocks List
Related ETFs - A few ETFs which own one or more of the above listed Familial Chylomicronemia Syndrome stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 4.31 | |
PBE | D | PowerShares Dynamic Biotech & Genome | 2.69 | |
HELX | D | Franklin Genomic Advancements ETF | 2.32 | |
BBP | D | BioShares Biotechnology Products Fund | 1.73 | |
LABD | B | Direxion Daily S&P Biotech Bear 3X Shares | 1.64 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 25 | IONS | Ionis Publishes 2023 Corporate Responsibility Report |
Apr 23 | IONS | Ionis to hold first quarter 2024 financial results webcast |
Related Industries:
Biotechnology
- Familial Chylomicronemia Syndrome
Lipoprotein lipase deficiency is a genetic disorder in which a person has a defective gene for lipoprotein lipase, which leads to very high triglycerides, which in turn causes stomach pain and deposits of fat under the skin, and which can lead to problems with the pancreas and liver, which in turn can lead to diabetes. The disorder only occurs if a child acquires the defective gene from both parents (it is autosomal recessive). It is managed by restricting fat in diet to less than 20 g/day.The condition has also been called familial chylomicronemia syndrome, chylomicronemia,. chylomicronemia syndrome, and hyperlipoproteinemia type Ia.
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles